Similar articles

• Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.

  Cruse JM, Whitten HD, Lewis GK, Watson ES. Cruse JM, et al. Transplant Proc. 1973 Mar;5(1):961-7. Transplant Proc. 1973. PMID: 4695960 No abstract available.
• Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

  Ralph P, Prichard J, Cohn M. Ralph P, et al. J Immunol. 1975 Feb;114(2 pt 2):898-905. J Immunol. 1975. PMID: 1089721
• Kinetic studies of macrophages. VI. The effect of the presence of a solid tumor.

  Gillette RW, Boone CW. Gillette RW, et al. J Reticuloendothel Soc. 1974 Feb;15(2):126-31. J Reticuloendothel Soc. 1974. PMID: 4815212 No abstract available.
• Mechanisms of immunological enhancement.

  Cruse JM, Lewis GK, Whitten HD, Watson ES, Fields JF, Adams ST Jr, Harvey GF 3rd, Paslay JW, Porter M. Cruse JM, et al. Prog Exp Tumor Res. 1974;19:110-56. Prog Exp Tumor Res. 1974. PMID: 4140539 Review. No abstract available.
• Immunologicc activity of the aged.

  Makinodan T, Perkins EH, Chen MG. Makinodan T, et al. Adv Gerontol Res. 1971;3:171-98. Adv Gerontol Res. 1971. PMID: 4398644 Review. No abstract available.